Peter A Fasching
No ORCID on file
· 42 papers in corpus
· active 2005-2026
Study types
- article 25
- other 13
- preprint 2
- journal-article 1
- review 1
Condition tags
- endometriosis 38
- mesh:D004715 19
- dysmenorrhea 5
- dyspareunia 4
- mesh:D017699 3
- die_deep_infiltrating 3
- adenomyosis 3
- mesh:D004414 1
- mesh:D004412 1
Top journals
- Archives of gynecology and obstetrics 4
- Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 3
- Fertility and sterility 2
- BMC cancer 2
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2
Frequent coauthors
other
2026
BACKGROUND: Endometriosis is heterogeneous, and evidence for individualised postoperative management is limited. We assessed whether postoperative hormonal therapy exposure is associated with one-year changes in pain domains after first-tim…
article
2026
Endometriosis is heterogeneous, and evidence for individualised postoperative management is limited. We assessed whether postoperative hormonal therapy exposure is associated with one-year changes in pain domains after first-time endometrio…
article
2026
Endometriosis is heterogeneous, and evidence for individualised postoperative management is limited. We assessed whether postoperative hormonal therapy exposure is associated with one-year changes in pain domains after first-time endometrio…
other
2025
PURPOSE: Endometriosis appears in various forms and symptoms. With regard to the established endometriosis classifications, it is hardly possible to draw conclusions from the endometriosis to the symptoms caused by it. The objective of this…
other
2025
BACKGROUND: Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology o…
article
2024
preprint
2023
AbstractBackground: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian canc…
preprint
2023
AbstractBackground: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian canc…
article
2023
2019 wurden in deutschen Krankenhäusern insgesamt 748492 Geburten registriert, 3 Jahre zuvor wurden knapp 133000 Patient*innen mit Mammakarzinom vollstationär behandelt 1 2. Ein Uterus myomatosus kann ab dem Alter von 50 Jahren bei mehr als…
other
2023
OBJECTIVE: The presence of macroscopic residual disease after primary cytoreductive surgery (PCS) is an important factor influencing survival for patients with high-grade serous ovarian cancer (HGSC). More research is needed to identify fac…
article
2023
OBJECTIVE: To evaluate blood-based biomarkers to detect endometriosis and/or adenomyosis across nine European centers (June 2014-April 2018). METHODS: This prospective, non-interventional study assessed the diagnostic accuracy of 54 blood-b…
article
2021
article
2021
PURPOSE: In many diseases, it is possible to classify a heterogeneous group into subgroups relative to tumor biology, genetic variations, or clinical and pathological features. No such classification is available for endometriosis. In our r…
article
2020
Einleitung: Die Endometriose ist mit ihren vielseitigen Erscheinungsformen ein Chamäleon unter den Erkrankungen. Eine eindeutige Ätiologie ist bislang nicht bekannt und die Heterogenität der klinischen Symptomatik erschwert die frühzeitige …
article
2020
Zielsetzung Endometriose ist eine heterogene Erkrankung mit unterschiedlichen Erscheinungsformen und Ausprägungsgrade. Eine Einteilung in Untergruppen ist bisher nicht bekannt. Ziel dieser Fall-Fall-Studie ist es, eine Population von Endome…
article
2020
Zielsetzung: Endometriose ist eine heterogene Erkrankung mit unterschiedlichen Erscheinungsformen und Ausprägungsgraden. Bisher existiert jedoch keine etablierte Einteilung in Untergruppen. Ziel dieser Fall-Fall-Studie ist es, eine Populati…
article
2019
Endometriosis is one of the most common benign gynecological diseases. The extremely heterogeneous complex of symptoms complicates the diagnosis and treatment of this disease. In most patients, there is a latency period of several years bet…
other
2018
We aimed to validate the prognostic association of p16 expression in ovarian high-grade serous carcinomas (HGSC) and to explore it in other ovarian carcinoma histotypes. p16 protein expression was assessed by clinical-grade immunohistochemi…
review
2018
Abstract Epidemiological, biological, and molecular data suggest links between endometriosis and endometrial cancer, with recent epidemiological studies providing evidence for an association between a previous diagnosis of endometriosis and…
article
2017
other
2017
Background: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian cancer patie…
other
2015
Disruption in circadian gene expression, whether due to genetic variation or environmental factors (e.g., light at night, shiftwork), is associated with increased incidence of breast, prostate, gastrointestinal and hematologic cancers and g…
article
2015
Background: No screening programs are available for ovarian or endometrial cancer. One reason for this is the low incidence of the conditions, resulting in low positive predictive values for tests, which are not very specific. One way of ad…
article
2015
article
2015
Endometriosis is a chronic disease of women in the reproductive age, defined as endometrial cells growing outside of the uterine cavity and associated with relapses. Relapses are hypothesized to correlate with incomplete surgical excision o…